Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)
about
A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patientsCost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA StudyReal-life effectiveness and tolerability of vildagliptin and other oral glucose-lowering therapies in patients with type 2 diabetes in Germany.Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data.Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE studyEffectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data.Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy.A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs.DPP-4 inhibitors: pharmacological differences and their clinical implications.Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc AnalysisManaging glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes.Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study.Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.Efficacy and tolerability of vildagliptin-based versus comparative dual therapy in type 2 diabetes : Results of the Austrian subpopulation of the EDGE study.Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study).
P2860
Q26995462-319A8BAF-445F-4707-BDF8-861E3D0EFC1EQ30234836-A8D69BD4-DC14-4241-BC49-35A899BF10E1Q33785141-E31C90AA-A80F-4F84-A72B-C3EDED1FBE98Q33785162-D7DAFB4D-0E0E-4954-8194-93576C4B7E56Q34726395-B62761CF-23CC-424A-B5F8-5523D11C8744Q35142675-FDAD70F9-3945-4E82-9382-171C474AB2D9Q35167496-66EEEB71-9AC9-43CC-92FB-EC9497308C76Q35887463-F2D86A61-DBC1-4524-B590-033C7F975133Q37151024-82578E04-76AD-43A5-9F45-170FE41AB124Q37610459-F103FB89-B8DB-4F35-A24B-4D75442B749BQ38244576-B7D7123C-A7DD-4E64-A147-997AD5BB6F60Q38718023-7BC43569-3C26-48BB-868A-180524A60E5CQ39062468-7E19D540-64BA-42E8-A73D-260D62916709Q39161794-F961176E-B08D-475A-A9F8-EDF6BD787A9CQ39454846-5BFDEB1F-0706-4ED6-8354-F15EDF048920Q40808660-F6C5750B-B2B1-4DF8-8BD9-A66021C8E43CQ41598367-9F59C20A-4B0F-4778-B390-5311E55818F4Q43187617-FEF15769-3369-4936-8DCD-2153291F5586
P2860
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effectiveness and tolerability ...... ide observational study (EDGE)
@ast
Effectiveness and tolerability ...... ide observational study (EDGE)
@en
Effectiveness and tolerability ...... worldwide observational study
@nl
type
label
Effectiveness and tolerability ...... ide observational study (EDGE)
@ast
Effectiveness and tolerability ...... ide observational study (EDGE)
@en
Effectiveness and tolerability ...... worldwide observational study
@nl
prefLabel
Effectiveness and tolerability ...... ide observational study (EDGE)
@ast
Effectiveness and tolerability ...... ide observational study (EDGE)
@en
Effectiveness and tolerability ...... worldwide observational study
@nl
P2093
P2860
P356
P1476
Effectiveness and tolerability ...... ide observational study (EDGE)
@en
P2093
A H Barnett
A Penfornis
E Márquez Rodriguez
E Pagkalos
J J de Castro
N C Schaper
P2860
P304
P356
10.1111/IJCP.12252
P577
2013-08-21T00:00:00Z